The suit alleges that PBMs, including CVS Caremark, Express Scripts and OptumRx, used their market power to drive up the cost of insulin for Cleveland residents — approximately 16.8% of whom are diabetic.
The suit alleges that PBMs, including CVS Caremark, Express Scripts and OptumRx, used their market power to drive up the cost of insulin for Cleveland residents — approximately 16.8% of whom are diabetic.